Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Flow from Investing Activities

    Back to Cashflow Statement
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Investing Activities ₹-477 Cr₹-434 Cr₹-1,339 Cr₹-1,812 Cr₹-4,480 Cr

What is the latest Cash Flow from Investing Activities ratio of PIRAMAL PHARMA ?

The latest Cash Flow from Investing Activities ratio of PIRAMAL PHARMA is ₹-477 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Investing Activities
Mar2025₹-477 Cr
Mar2024₹-434 Cr
Mar2023₹-1,339 Cr
Mar2022₹-1,812 Cr
Mar2021₹-4,480 Cr

How is Cash Flow from Investing Activities of PIRAMAL PHARMA Trending?

Years Cash Flow from Investing Activities % Change
Mar2025 ₹-477 Cr
Negative
Mar2024 ₹-434 Cr
Negative
Mar2023 ₹-1,339 Cr
Negative
Mar2022 ₹-1,812 Cr
Negative
Mar2021 ₹-4,480 Cr -

Compare Cash Flow from Investing Activities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹21,054.5 Cr 4.5% -12% -30.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,439.0 Cr 5.7% -3.3% -2.2% Stock Analytics
DIVIS LABORATORIES ₹162,903.0 Cr 1.6% -7.6% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,466.0 Cr -0.5% 0.9% 23.6% Stock Analytics
CIPLA ₹107,653.0 Cr 0.5% -12.9% -10.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,924.0 Cr 5.3% -0.9% 1.9% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

4.5%

-12%

-30.2%

SENSEX

1.3%

-2.5%

8.5%


You may also like the below Video Courses